Cargando…
In vitro proliferation of human osteogenic cells in presence of different commercial bone substitute materials combined with enamel matrix derivatives
BACKGROUND: Cellular reactions to alloplastic bone substitute materials (BSM) are a subject of interest in basic research. In regenerative dentistry, these bone grafting materials are routinely combined with enamel matrix derivatives (EMD) in order to additionally enhance tissue regeneration. MATERI...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2780983/ https://www.ncbi.nlm.nih.gov/pubmed/19909545 http://dx.doi.org/10.1186/1746-160X-5-23 |
_version_ | 1782174544470999040 |
---|---|
author | Reichert, Christoph Al-Nawas, Bilal Smeets, Ralf Kasaj, Adrian Götz, Werner Klein, Marcus O |
author_facet | Reichert, Christoph Al-Nawas, Bilal Smeets, Ralf Kasaj, Adrian Götz, Werner Klein, Marcus O |
author_sort | Reichert, Christoph |
collection | PubMed |
description | BACKGROUND: Cellular reactions to alloplastic bone substitute materials (BSM) are a subject of interest in basic research. In regenerative dentistry, these bone grafting materials are routinely combined with enamel matrix derivatives (EMD) in order to additionally enhance tissue regeneration. MATERIALS AND METHODS: The aim of this study was to evaluate the proliferative activity of human osteogenic cells after incubation over a period of seven days with commercial BSM of various origin and chemical composition. Special focus was placed on the potential additional benefit of EMD on cellular proliferation. RESULTS: Except for PerioGlas(®), osteogenic cell proliferation was significantly promoted by the investigated BSM. The application of EMD alone also resulted in significantly increased cellular proliferation. However, a combination of BSM and EMD resulted in only a moderate additional enhancement of osteogenic cell proliferation. CONCLUSION: The application of most BSM, as well as the exclusive application of EMD demonstrated a positive impact on the proliferation of human osteogenic cells in vitro. In order to increase the benefit from substrate combination (BSM + EMD), further studies on the interactions between BSM and EMD are needed. |
format | Text |
id | pubmed-2780983 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-27809832009-11-24 In vitro proliferation of human osteogenic cells in presence of different commercial bone substitute materials combined with enamel matrix derivatives Reichert, Christoph Al-Nawas, Bilal Smeets, Ralf Kasaj, Adrian Götz, Werner Klein, Marcus O Head Face Med Research BACKGROUND: Cellular reactions to alloplastic bone substitute materials (BSM) are a subject of interest in basic research. In regenerative dentistry, these bone grafting materials are routinely combined with enamel matrix derivatives (EMD) in order to additionally enhance tissue regeneration. MATERIALS AND METHODS: The aim of this study was to evaluate the proliferative activity of human osteogenic cells after incubation over a period of seven days with commercial BSM of various origin and chemical composition. Special focus was placed on the potential additional benefit of EMD on cellular proliferation. RESULTS: Except for PerioGlas(®), osteogenic cell proliferation was significantly promoted by the investigated BSM. The application of EMD alone also resulted in significantly increased cellular proliferation. However, a combination of BSM and EMD resulted in only a moderate additional enhancement of osteogenic cell proliferation. CONCLUSION: The application of most BSM, as well as the exclusive application of EMD demonstrated a positive impact on the proliferation of human osteogenic cells in vitro. In order to increase the benefit from substrate combination (BSM + EMD), further studies on the interactions between BSM and EMD are needed. BioMed Central 2009-11-12 /pmc/articles/PMC2780983/ /pubmed/19909545 http://dx.doi.org/10.1186/1746-160X-5-23 Text en Copyright ©2009 Reichert et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Reichert, Christoph Al-Nawas, Bilal Smeets, Ralf Kasaj, Adrian Götz, Werner Klein, Marcus O In vitro proliferation of human osteogenic cells in presence of different commercial bone substitute materials combined with enamel matrix derivatives |
title | In vitro proliferation of human osteogenic cells in presence of different commercial bone substitute materials combined with enamel matrix derivatives |
title_full | In vitro proliferation of human osteogenic cells in presence of different commercial bone substitute materials combined with enamel matrix derivatives |
title_fullStr | In vitro proliferation of human osteogenic cells in presence of different commercial bone substitute materials combined with enamel matrix derivatives |
title_full_unstemmed | In vitro proliferation of human osteogenic cells in presence of different commercial bone substitute materials combined with enamel matrix derivatives |
title_short | In vitro proliferation of human osteogenic cells in presence of different commercial bone substitute materials combined with enamel matrix derivatives |
title_sort | in vitro proliferation of human osteogenic cells in presence of different commercial bone substitute materials combined with enamel matrix derivatives |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2780983/ https://www.ncbi.nlm.nih.gov/pubmed/19909545 http://dx.doi.org/10.1186/1746-160X-5-23 |
work_keys_str_mv | AT reichertchristoph invitroproliferationofhumanosteogeniccellsinpresenceofdifferentcommercialbonesubstitutematerialscombinedwithenamelmatrixderivatives AT alnawasbilal invitroproliferationofhumanosteogeniccellsinpresenceofdifferentcommercialbonesubstitutematerialscombinedwithenamelmatrixderivatives AT smeetsralf invitroproliferationofhumanosteogeniccellsinpresenceofdifferentcommercialbonesubstitutematerialscombinedwithenamelmatrixderivatives AT kasajadrian invitroproliferationofhumanosteogeniccellsinpresenceofdifferentcommercialbonesubstitutematerialscombinedwithenamelmatrixderivatives AT gotzwerner invitroproliferationofhumanosteogeniccellsinpresenceofdifferentcommercialbonesubstitutematerialscombinedwithenamelmatrixderivatives AT kleinmarcuso invitroproliferationofhumanosteogeniccellsinpresenceofdifferentcommercialbonesubstitutematerialscombinedwithenamelmatrixderivatives |